Morgan partnered with Cure Our Ovarian Cancer and Memorial Sloan Kettering Cancer Center to raise funds for her rare cancer, low-grade serous ovarian carcinoma. 

Many of the most important breakthroughs in cancer research and treatment have been brought to light at Memorial Sloan Kettering, and none of that progress would have been possible without support from people like you. 

Morgan believes that with more research and more awareness we can improve survival rates for ovarian cancer. No one should have to be lucky to find their cancer. And no one should face five-year survival rates of less than 15%.